| BMC Nephrology | |
| Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project) | |
| Research | |
| Maurizio Nordio1  Silvia Pierobon1  Eliana Ferroni1  Maria Elena Bracaccia2  Paolo Menè2  Ersilia Lucenteforte3  Alessandro C. Rosa4  Arianna Bellini4  Marina Davoli4  Valeria Belleudi4  Marco Finocchietti4  Antonio Addis4  Nera Agabiti4  Olivia Leoni5  Stefano Ledda6  Donatella Garau6  Gaia Bedeschi7  Lucia Masiero7  Massimo Cardillo7  Marco Massari8  Stefania Spila Alegiani8  Giuseppe Piccolo9  | |
| [1] Azienda Zero of the Veneto Region, Padua, Italy;Department of Clinical Sciences, Division of Nephrology, University of Rome La Sapienza, Sant’Andrea University Hospital, Rome, Italy;Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy;Department of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Via Cristoforo Colombo, 112, 00147, Rome, Italy;Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy;General Directorate for Health, Sardinia Region, Cagliari, Italy;Italian National Transplant Centre, Istituto Superiore Di Sanità, Rome, Italy;National Centre for Drug Research and Evaluation, Istituto Superiore Di Sanità, Rome, Italy;Regional Transplant Coordination, Lombardy Region, Milan, Italy; | |
| 关键词: Immunosuppressive therapy; Determinants; Kidney; Real world evidence; Spatio-temporal variability; | |
| DOI : 10.1186/s12882-023-03325-9 | |
| received in 2023-05-10, accepted in 2023-09-06, 发布年份 2023 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundVery scanty evidence is available on factors influencing the choice of immunosuppressive drug therapy after kidney transplantation.MethodsAn Italian multiregional real-world study was conducted integrating national transplant information system and claims data. All patients undergoing kidney transplantation for the first time during 2009–2019 (incident patients) were considered. Multilevel logistic models were used to estimate Odds Ratio (OR) and corresponding 95% Confidence intervals. Factors with statistically significance were identified as characteristics associated with treatment regimens: cyclosporin-CsA vs tacrolimus-Tac and, within the latter group, mTOR inhibitors vs mycophenolate-MMF.ResultsWe identified 3,622 kidney patients undergoing transplantation in 17 hospitals located in 4 Italian regions, 78.3% was treated with TAC-based therapy, of which 78% and 22% in combination with MMF and mTOR, respectively. For both comparison groups, the choice of immunosuppressive regimens was mostly guided by standard hospital practices. Only few recipient and donor characteristics were found associated with specific regimen (donor/receipt age, immunological risk and diabetes).ConclusionsThe choice of post-renal transplant immunosuppressive therapy seems to be mostly driven by standard Centre practices, while only partially based on patient’s characteristics and recognized international guidelines.
【 授权许可】
CC BY
© The Author(s) 2023
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202311102354485ZK.pdf | 3144KB | ||
| Fig. 3 | 2506KB | Image | |
| MediaObjects/40538_2023_474_MOESM9_ESM.xlsx | 13KB | Other | |
| 12951_2015_155_Article_IEq56.gif | 1KB | Image | |
| Fig. 3 | 235KB | Image | |
| Fig. 6 | 797KB | Image | |
| Fig. 4 | 270KB | Image | |
| MediaObjects/13046_2023_2843_MOESM3_ESM.docx | 27KB | Other | |
| Fig. 7 | 245KB | Image | |
| Fig. 1 | 446KB | Image |
【 图 表 】
Fig. 1
Fig. 7
Fig. 4
Fig. 6
Fig. 3
12951_2015_155_Article_IEq56.gif
Fig. 3
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
PDF